REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Number of holders
442
Total 13F shares, excl. options
58,017,175
Shares change
+578,387
Total reported value, excl. options
$7,215,764,205
Value change
+$69,143,795
Put/Call ratio
864%
Number of buys
199
Number of sells
241
Price
$124.38

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2025

As of 30 Jun 2025 REPLIGEN CORP - COMMON STOCK (RGEN) had 527 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 58,017,175 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., STATE STREET CORP, FMR LLC, Champlain Investment Partners, LLC, Invesco Ltd., Bank of New York Mellon Corp, and SANDS CAPITAL MANAGEMENT, LLC.
This table shows 527 institutional shareholders of the security as of 30 Jun 2025.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.